Informed Consent

Researchers report that dangerous side effects are not being adequately reported in the trials of ketamine for depression.

School aged children exposed prenatally to psychotropic medication show poorer outcomes in cognitive ability.

A large review and meta-analysis of 167 studies across 60 years dissects placebo-controlled randomized controlled trials of antipsychotic drugs.

Researchers interviewed doctors about the barriers that prevent them from being able to decrease excess medications.

Researchers find that support and self-care were helpful for users during discontinuation, but that mental health professionals were not very helpful.

The researchers found that, of those who were initially prescribed both antidepressants and benzodiazepines, approximately 12% went on to engage in long-term benzodiazepine use.

Survey examines adverse personal and interpersonal effects of antidepressants and the impact of polypharmacy

A large longitudinal study finds once more that being prescribed antipsychotics significantly increases the risk of diabetes.

Review study compares outcomes of gradual vs. immediate antipsychotic discontinuation when switching from one drug to another.

A new training program teaches medical residents how to provide appropriate care and services to transgender clients.

A large observational study published in CNS Drugs sheds light on serious adverse effects of the ‘gold standard’ antipsychotic Clozapine.

Surveyed doctors overestimate pharmacological effects of antidepressants and underestimate placebo effects.

Contrary to widely-held belief, a new rigorous trial finds that ketamine is ineffective for delirium and pain associated with surgery, and the drug carries harmful side effects.

In a new report, the United Nations Special Rapporteur on the right to health, Dr. Dainius Pūras, calls for a move away from the biomedical model and “excessive use of psychotropic medicines.”

A new article explains common misconceptions about ADHD that are held by teachers and mental health professionals and may lead to overdiagnosis and overmedication in schools.

Veterans diagnosed with PTSD and taking SSRIs, novel antidepressants, or atypical antipsychotics are more likely to develop dementia.

Researcher examines the impact of client feedback and progress assessment on improvement in outcomes.

Implementing policies that regulate pharmaceutical sales representatives’ interaction with physicians may reduce prescription of promoted drugs.

Amid calls for a retraction, Lancet Psychiatry publishes articles criticizing the original finding and a response from the authors.

Important assessment tool found to underestimate the risk for fracture in patients on psychiatric medication.

A new study published in JAMA Internal Medicine, the largest study of its kind, has shown it is possible to reduce the use of antipsychotics in nursing homes, by engaging their staff in a training program designed to target residents’ strengths and their unmet needs.

In July of 2010, Stewart Dolin, a partner at the mega law firm Reed Smith, jumped in front of a subway train in Chicago, apparently suffering from akathisia caused by paroxetine. His widow sued, and the jury found GSK negligent in not informing doctors of the suicide risk

Data shows that over a third of users experience permanent memory loss and that approximately half report not receiving adequate information about the risks from their doctors.

Between 2,150 and 4,100 children suffered from severe malformations connected to valproate prescription.

Recommendations on how to provide trauma-informed, short-term counseling to college students who have experienced sexual assault and interpersonal violence.